Objective:

To present long-term results of high-energy extracorporeal shock wave therapy (ESWT) for chronic phase Peyronie’s disease using two different electromagnetic lithotripters, highlighting its significance in the context of existing treatment options.

Key Findings:

• 85 patients had sufficient data for long-term follow-up after excluding those with previous treatments or lost to follow-up, with significant improvements noted in curvature and pain scores.
• The median duration of Peyronie’s disease was 14 months, with a median age of 54 years, and specific statistical outcomes were recorded.
• Patients reported varying degrees of curvature and pain, which were assessed using specific scales, with detailed results provided.

Interpretation:

High-energy ESWT may provide a viable treatment option for chronic Peyronie’s disease, potentially improving curvature and pain management compared to existing therapies.

Limitations:

• Retrospective design may introduce bias.
• Loss of follow-up for some patients could affect the results.
• Sample size may limit the generalizability of the findings.

Conclusion:

High-energy ESWT shows promise in managing chronic Peyronie’s disease, warranting further investigation in larger, controlled studies, particularly focusing on long-term outcomes and comparisons with other treatment modalities.